Pharmaceutical

Eli Lilly to invest $4.5bn for drug manufacturing and trial medicine production

Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing medicines for clinical trials.

Oct 4, 2024 - 04:00
Eli Lilly to invest $4.5bn for drug manufacturing and trial medicine production
Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing medicines for clinical trials.
Read the original article

Tags:

Previous Article

Gilead signs agreements to facilitate access to HIV prevention drug

Next Article

Social media algorithms are driving the GLP-1 drugs boom

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

ESC 2024: Study highlights potential for Novartis to differentiate in HF space

ESC 2024: Study highlights potential for Novartis to di...

Sep 2, 2024

NHS proposes phased launch for Eli Lilly’s Mounjaro

NHS proposes phased launch for Eli Lilly’s Mounjaro

Oct 6, 2024

BioMarin Pharmaceutical gets grant for treatment of adolescent PKU patients using avpal variant

BioMarin Pharmaceutical gets grant for treatment of ado...

Jun 12, 2024